Results 71 to 80 of about 3,123 (163)
Canadian Journal of Infectious Diseases and Medical Microbiology, Volume 2026, Issue 1, 2026.Background Antimicrobial resistance (AMR) is one of the most critical health concerns of the 21st century, leading to increased mortality, prolonged hospital stays for patients, and higher healthcare costs. Despite urgency of AMR issue, comprehensive and comparative data on AMR in the Middle East region remain limited.
Sarina Alidadpour +7 more
wiley +1 more source
Infectious Diseases and Therapy, 2020 Introduction Acute bacterial skin and skin structure infections (ABSSSI) are an increasing cause of admission in the self-pay population. We previously reported that patients with ABSSSI discharged to receive dalbavancin showed a decreased length of stay
Adam G. Pizzuti +5 more
doaj +1 more source
An Uncommon Presentation of Sweet’s Syndrome in Primary Myelofibrosis
Case Reports in Hematology, Volume 2026, Issue 1, 2026.Sweet’s syndrome (SS) is a rare neutrophilic dermatosis often associated with hematologic malignancies. Due to its infectious mimicry, diagnosis is frequently delayed. We report a case of primary myelofibrosis initially treated for suspected cellulitis, which progressed to necrotic lesions and refractory fever despite broad‐spectrum antibiotics. A skin
Valentina Rago +7 more
wiley +1 more source
The Role of ACE2 in SARS‐CoV‐2 Infection, Pathogenesis, and Antiviral Interventions
Journal of Medical Virology, Volume 97, Issue 12, December 2025.ABSTRACT The devastating clinical, psychological, and economic impact of the COVID‐19 pandemic, caused by global spread of the second Severe Acute Respiratory Syndrome Coronavirus (SARS‐CoV‐2), has engendered a massive response from the scientific community to rapidly understand the biology of SARS‐CoV‐2 and to develop interventions to prevent ...
Michael A. McVoy +1 more
wiley +1 more source
Dalbavancin in the treatment of complicated skin and soft-tissue infections: a review
, 2008 Jason W Bennett1, James S Lewis II2, Michael W Ellis11Department of Medicine-Infectious Disease Service, Brooke Army Medical Center, Fort Sam Houston, TX, USA; 2Department of Medicine-Division of Infectious Diseases, University of Texas Health Science ...
Michael W Ellis +2 more
core
Managing the Complex Intersection Between Substance Use Disorders and Infectious Diseases
JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY, Volume 9, Issue 3, March 2026.
Karissa Chow +4 more
wiley +1 more source
Antibiotic Resistance: A Genetic and Physiological Perspective
MedComm, Volume 6, Issue 11, November 2025.The development of resistance to antimicrobials and their historical progression are depicted in this graphic. It draws attention to important biochemical, physiological, and genetic factors that contribute to AMR, such as the transmission of genes, the development of biofilms, and the inactivation of antibiotics.
Rania G. Elbaiomy +9 more
wiley +1 more source
, 2016 Kimberly D Leuthner,1 Kristin A Buechler,1 David Kogan,1 Agafe Saguros,1 H Stephen Lee2 1Department of Pharmaceutical Services, University Medical Center of Southern Nevada, Las Vegas, NV, USA; 2Roseman University of Health Sciences College of Pharmacy,
Leuthner KD +4 more
core
Role of dalbavancin as combination therapy: evidence from the literature and clinical scenarios
, 2022 Introduction The off-label use of dalbavancin in patients with infections other than acute bacterial skin and skin structure infections (ABSSSI) represents an interesting therapeutic option. Its use as monotherapy or in combination with other antibiotics
Bruno Cacopardo +17 more
core +1 more source
, 2017 Objectives: Combination therapies have a distinct advantage over monotherapies in terms of their broad spectrum, synergistic effect and prevention of the emergence of drug resistance.
Derbentli, Sengul, Aktas, Gülseren
core +1 more source